The Investors forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, med tech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company or university to all major Dutch life sciences investors and discuss your business strategy, technology direction and capital-raising plan.
Participate in the Investors Forum and grab your chance to meet with interesting partners, initiate strategic alliances or tap into the international financing networks.
The Investors Forum enables you to evaluate new investment opportunities and to meet with the management of the most promising life sciences companies, start-ups as well as established ventures. After the forum there will be ample opportunity to further discuss future collaborations in one-on-one meetings.
- Berkvens Management & Investment BV
- BioGeneration Ventures
- Brabantse Ontwikkelings Maatschappij (BOM)
- Carduso Capital
- Curie Capital
- DDF Ventures
- Earlybird Venture Capital
- Ekoy Investment Partners
- GoldNest Private Capital SPC
- Inkef Capital
- Innovation Quarter
- KIKK Capital
- NLC Ventures Netherlands
- PHA - Philipp Hess Associates
- Swanbridge Capital
- Thuja Capital
The forum offers excellent opportunities for presenting your company to all major Dutch life sciences investors and discussing your business strategy, technology direction and capital-raising plan. Prior to the event, companies will be invited to participate in a number of dry-run presentations. The steering committee will provide feedback and give advice. The winner of the Investors Forum will be awarded a partnering ticket, national or international, with a total value of EUR 2,500 and will be allowed to repeat the winning pitch in the plenary program. Upon registration you will be given further details.
- Levels Diagnostics
- Madam Therapeutics
- Panorama Laboratories
- River BioMedics
General information and registration
The Investors Forum is open to representatives of pharma and biotech companies (manufacturing, service providers and research & development), investors and technology transfer departments at universities. Participation will be reviewed by the Investors Forum Committee and is on a first-come, first-served basis. The Investors Forum may be sold out.
During the conference the forum will be held in two sessions:
- Part 1 - breakfast session (08:00 - 09:00)
- Part 2 - lunch session (12:30 - 13:30)
This will enable participants to attend the plenary programme of the conference as well. Participation in the Investors Forum involves no additional costs. Conference registration is all that is required. If you are interested in participating in the Investors Forum, please contact Miranda de Regt at email@example.com.